EH
Ernst Heinen
Chief Development Officer

Ernst Heinen insider trades: Aratana Therapeutics (PETX) stock sales

Chief Development Officer, Aratana Therapeutics Last trade Nov 7, 2018 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2014
1
Company
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ernst reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 7, 2018PETX↓ Sell$134K
Nov 2, 2018PETX↓ Sell$5K
Aug 14, 2018PETX↓ Sell$53K
Aug 10, 2018PETX↓ Sell$24K
Sep 15, 2017PETX↓ Sell$63K
Oct 3, 2016PETX↓ Sell$100K
Jun 10, 2016PETX↓ Sell$101K
Jul 15, 2015PETX↓ Sell$256K
May 5, 2014PETX↓ Sell$134K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ernst Heinen's insider trades

Ernst Heinen is Chief Development Officer at Aratana Therapeutics (PETX). Since May 5, 2014, Ernst has reported no open-market purchases and 9 sales worth $870K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PETX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.